ClinicalTrials.Veeva

Menu

Real World Data Collection on the Synergy Cervical Disc

S

Synergy Spine Solutions

Status

Enrolling

Conditions

Cervical Disc Degeneration

Treatments

Device: Synergy Cervical Disc System

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05305430
CP 21-001

Details and patient eligibility

About

This trial is a real world data (RWD) collection observational study, comprised of both prospective and retrospective arms, that will examine the safety and effectiveness of the Synergy Cervical Disc System in patients with degenerative cervical disc disease.

Enrollment

200 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Over the age of 21 at the time of the surgery.
  2. Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted
  3. Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
  4. Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression: herniated disc and/or osteophyte formation
  5. Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.)
  6. Failed a minimum of 6 weeks conservative treatment
  7. Written informed consent given by subject, as applicable.

Exclusion criteria

  1. Moderate to advanced spondylosis
  2. Diagnosis of osteoporosis
  3. Active systemic infection or infection at the operative site
  4. Pregnancy
  5. Marked cervical instability on lateral, coronal, or flexion/extension radiographs
  6. Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level
  7. Severe pathology of the facet joints of the involved vertebral bodies
  8. Previous diagnosis of osteopenia or osteomalacia
  9. More than one immobile vertebral level between C1 and T1 from any cause
  10. Morbid obesity
  11. Currently a prisoner

Trial design

200 participants in 2 patient groups

Prospective
Description:
All patients for whom the decision has been made to have the Synergy Disc implanted at participating investigative centers and give informed consent to participate in the prospective segment of this protocol, per country-specific requirements, will be enrolled in the prospective portion of this protocol.
Treatment:
Device: Synergy Cervical Disc System
Retrospective
Description:
Patients who have previously had a Synergy Spine Solutions Synergy Disc implanted will be eligible for inclusion in the retrospective data collection; a waiver of consent, or informed consent, for retrospective data collection from the medical records of the implanting surgeon will be sought per country-specific regulations as applicable.
Treatment:
Device: Synergy Cervical Disc System

Trial contacts and locations

3

Loading...

Central trial contact

Christine Nimalasiri; Jane M Jacob, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems